Compound heterozygosity of a previously described pathogenic variant and a second novel nucleotide substitution (NR_023343.1:n.116A>C) affecting a highly conserved nucleotide in the noncoding RNU4ATAC gene could be identified in a patient with overlapping features of Roifman Syndrome. These data extend the spectrum of pathogenic variants in RNU4ATAC.
CITATION STYLE
Hallermayr, A., Graf, J., Koehler, U., Laner, A., Schönfeld, B., Benet-Pagès, A., & Holinski-Feder, E. (2018). Extending the critical regions for mutations in the non-coding gene RNU4ATAC in another patient with Roifman Syndrome. Clinical Case Reports, 6(11), 2224–2228. https://doi.org/10.1002/ccr3.1830
Mendeley helps you to discover research relevant for your work.